7.900
+0,00%
2026-10-19
Fundamental Analysis
24 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -429.3% | -150.7% | 1 / 3 | +18.4% | -8.13 pp | -7.76 pp | -3.0% | 1.21 | — | 395 | +18,4% | −38,5 | −482,3% | — | 25.37 | — |
| Pts | 0 | 0 | 4 | 8 | 0 | 0 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 7.900 (close price on 2026-10-19)EPS (TTM): −312,3
Financial charts
1.Revenue & growth
VND bn395Q2/26
1.Revenue & growth
VND bn395Q2/26
2.Profit & growth
VND bn-38,5Q2/26
3.Profit mix (Penman)
VND bn-22,4Q2/26
4.Margins & cost structure
%16.1%Q2/26
5.Returns & cash cycle
% · days2.8%Q2/26
6.Earnings quality & cash
VND bn-208Q2/26
7.Asset structure
VND bn3.927Q2/26
8.Funding & debt health
VND bn · times3.927Q2/26
9.Revenue backlog
VND bn22,8Q2/26
10.Valuation
times · %-24,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-275Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-197%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26